Key facts
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vita Spot
- ·The full record, as it builds
Funding rounds
No funding rounds for Vita Spot are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vita Spot
Developer of a preventative pet wellness platform designed to enable early detection of illness in companion animals. The company's platform integrates blood biomarker analysis, whole body imaging, telehealth veterinary consultations, and personalized wellness planning, providing pet owners with comprehensive health monitoring, actionable reports, and ongoing tracking to identify risks such as cancer, organ disease, and genetic conditions at an early stage, enabling proactive care and improved long-term health outcomes for pets.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Australia
- Website
- vita-spot.com/
- Ownership
- Privately Held (backing)
Vita Spot doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vita Spot shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vita Spot in its N-PORT filings yet. We sweep new filings monthly.